|
Market Closed -
NYSE
04:00:02 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 118.21 USD | -0.44% |
|
-2.88% | +47.49% |
| Oct. 19 | Haemonetics Gets FDA Approval for Vascular Closure Device | DJ |
| Oct. 19 | Haemonetics says FDA clears vascular closure device | RE |
| Market Cap | 5.38B 4.79B 4.44B 4.02B 7.56B 509B 7.68B 53.24B 20.91B 267B 20.17B 19.76B 851B | P/E 2027 * |
29.8x | P/E 2028 * | 26.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.04B 5.38B 4.98B 4.52B 8.49B 572B 8.63B 59.79B 23.49B 299B 22.66B 22.19B 955B | EV / Sales 2027 * |
4.26x | EV / Sales 2028 * | 3.82x |
| Free-Float |
98.74% | Yield 2027 * |
0.85% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed | |
|
Boerse Muenchen
| HAZ | Real-time | |
|
Tradegate
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | -0.44% | ||
| 1 week | -2.88% | ||
| Current month | +12.26% | ||
| 1 month | +9.05% | ||
| 3 months | +51.22% | ||
| 6 months | +93.25% | ||
| Current year | +47.49% |
| 1 week | 117 |  | 122.46 |
| 1 month | 101.32 | | 123.77 |
| Current year | 51 | | 123.77 |
| 1 year | 48.98 | | 123.77 |
| 3 years | 47.32 | | 123.77 |
| 5 years | 43.5 | | 123.77 |
| 10 years | 32.76 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2016-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 2022-04-10 |
Frank Chan
COO | Chief Operating Officer | 56 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 2005-12-31 |
| Director/Board Member | 62 | 2016-05-15 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 2017-10-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.44% | -2.88% | +133.11% | +32.75% | 5.38B | |
| -1.55% | -0.16% | -20.89% | +5.86% | 177B | |
| +2.17% | +7.73% | -20.15% | +14.57% | 117B | |
| +2.00% | +1.74% | -1.34% | +30.17% | 116B | |
| +14.49% | +16.00% | -45.74% | +3.81% | 77.71B | |
| +0.96% | +3.99% | +4.85% | +81.86% | 65.51B | |
| +1.98% | +4.35% | +15.64% | +82.79% | 54.97B | |
| +1.60% | +3.43% | +1.47% | -25.07% | 52.79B | |
| +0.38% | +7.23% | -13.29% | +30.66% | 43.95B | |
| -0.28% | +0.80% | +25.30% | -0.27% | 32.35B | |
| Average | +2.10% | +2.76% | +7.90% | +25.71% | 74.25B | |
| Weighted average by Cap. | +2.12% | +3.00% | -10.18% | +22.40% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.26B 1.17B 1.06B 1.99B 134B 2.02B 14.02B 5.51B 70.24B 5.31B 5.2B 224B | 1.5B 1.33B 1.23B 1.12B 2.1B 142B 2.14B 14.8B 5.81B 74.13B 5.61B 5.49B 236B |
| Net income | 177M 158M 146M 133M 249M 16.81B 253M 1.76B 690M 8.8B 666M 652M 28.06B | 207M 184M 171M 155M 291M 19.63B 296M 2.05B 806M 10.27B 777M 761M 32.77B |
| Net Debt | 662M 589M 546M 495M 930M 62.71B 946M 6.55B 2.57B 32.82B 2.48B 2.43B 105B | 327M 291M 270M 245M 460M 30.99B 467M 3.24B 1.27B 16.22B 1.23B 1.2B 51.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $118.21 | -0.44% | 585,002 |
| 26-10-19 | $118.73 | +0.38% | 392,221 |
| 26-10-16 | $118.28 | -2.48% | 471,521 |
| 26-10-15 | $121.29 | +0.15% | 747,647 |
| 26-10-14 | $121.11 | -0.50% | 592,144 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
